TY - JOUR
KW - Adolescent
KW - Adult
KW - Humans
KW - Ad26COVS1/adverse effects
KW - BNT162 Vaccine/adverse effects
KW - Cohort Studies
KW - COVID-19/epidemiology/prevention & control
KW - *COVID-19 Vaccines/adverse effects
KW - *Thrombocytopenia/epidemiology
KW - *Thromboembolism/epidemiology
KW - *Thrombosis/epidemiology
KW - Venous Thrombosis/epidemiology
AU - X. Li
AU - E. Burn
AU - T. Duarte-Salles
AU - C. Yin
AU - C. Reich
AU - A. Delmestri
AU - K. Verhamme
AU - P. Rijnbeek
AU - M. Suchard
AU - K. Li
AU - M. Mosseveld
AU - L. John
AU - M. Mayer
AU - J. Ramirez-Anguita
AU - C. Cohet
AU - V. Strauss
AU - D. Prieto-Alhambra
AD - Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK Edward.burn@ndorms.ox.ac.uk.
Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
Real World Solutions, IQVIA, Durham, NC, USA.
Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.
Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA.
Department of Human Genetics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, USA.
Research Programme on Biomedical Informatics, Hospital del Mar Medical Research Institute, Faculty of Health and Life Sciences, University of Pompeu Fabra, Barcelona, Spain.
Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, Netherlands.
AN - 36288813
BT - Bmj
C2 - PMC9597610 at www.icmje.org/disclosure-of-interest/ and declare: support from the EMA for the submitted work; DP-A receives funding from the UK National Institute for Health Research (NIHR) in the form of a senior research fellowship and from the Oxford NIHR Biomedical Research Centre. XL receives the Clarendon Fund and Brasenose College scholarship (University of Oxford) to support her DPhil study. DP-A’s research group has received research grants from the EMA; Innovative Medicines Initiative; and Amgen, Chiesi, and UCB Biopharma; and consultancy or speaker fees from Astellas, Amgen, AstraZeneca, and UCB Biopharma. LHJ works for a research group who receives unconditional research grants from Yamanouchi, Pfizer-Boehringer Ingelheim, Novartis, GSK, Chiesi, Astra-Zeneca, Amgen, Janssen Research and Development. PR works for a research group who receives unconditional research grants from Yamanouchi, Pfizer-Boehringer Ingelheim, Novartis, GSK, Chiesi, Astra-Zeneca, Amgen, Janssen Research and Development. CC has no conflicts of interest. None of these declarations relate to the content of this paper.
DO - 10.1136/bmj-2022-071594
DP - NLM
ET - 2022/10/27
LA - eng
N1 - 1756-1833
Li, Xintong
Orcid: 0000-0002-6872-5804
Burn, Edward
Orcid: 0000-0002-9286-1128
Duarte-Salles, Talita
Yin, Can
Reich, Christian
Delmestri, Antonella
Verhamme, Katia
Rijnbeek, Peter
Suchard, Marc A
Li, Kelly
Mosseveld, Mees
John, Luis H
Mayer, Miguel-Angel
Ramirez-Anguita, Juan-Manuel
Cohet, Catherine
Strauss, Victoria
Prieto-Alhambra, Daniel
Journal Article
Meta-Analysis
BMJ. 2022 Oct 26;379:e071594. doi: 10.1136/bmj-2022-071594.
PY - 2022
SN - 0959-8138 (Print)
0959-8138
EP - e071594
T2 - Bmj
TI - Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US
VL - 379
ER -